Pharming submits a Marketing Authorisation Application to the ... - 11 October 2022 16:00

LEIDEN, Netherlands, Oct. 11, 2022 /PRNewswire-AsiaNet/ -- -- Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency -- This submission follows the grant of accelerated assessment allowing an expedited review ...

  Translumina further strengthens senior leadership to drive nex... - 11 October 2022 01:29

NEW DELHI, Oct. 10, 2022 /PRNewswire-Asianet/ Translumina - a global developer and manufacturer of innovative cardiovascular medical devices, implants and access products - appointed Indranil Mukherjee as Group CEO and Armin Kiser as Managing Director and Chief Operating Officer for the c...

  Pierre Fabre is taking a minority stake, via its dedicated inv... - 10 October 2022 18:00

CASTRES, France and VITROLLES, France, October 10, 2022, PRNewswire-AsiaNet/-- Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets. - Gennisium finds a strategic ...

  On World Mental Health Day, NCCN Announces Free Updated Distre... - 10 October 2022 10:34

PLYMOUTH MEETING, Pa., Oct. 10, 2022 /PRNewswire-AsiaNet/ -- -- The National Comprehensive Cancer Network's Distress Thermometer helps people with cancer worldwide receive better care by empowering discussion and recommending best practices for managing psychological wellness. The National Comprehensive ...

  Mediterranean diet improves immunotherapy response rates and p... - 09 October 2022 09:01

VIENNA Oct. 8, 2022 /PRNewswire-AsiaNet/ Eating a Mediterranean diet, rich in fibre, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunotherapy response rates and progression-free survival in advanced melanoma patients, a new study presented today at UE...

  Synapse Medicine Initiates Multi-Site Implementation Study wit... - 07 October 2022 02:00

NEW YORK, Oct. 6, 2022, /PRNewswire-AsiaNet/ -- • Synapse Medicine clinical decision support technology analyzes drug-related risks based on each patient's clinical characteristics and will be studied for its impact on inpatient pharmacist efficacy and efficiency. • The Synapse Medicine medica...

  TauRx Announces Results from Phase 3 Alzheimer's Disease Study... - 06 October 2022 21:00

ABERDEEN, Scotland and SINGAPORE, Oct. 6, 2022 /PRNewswire-AsiaNet/ -- - For people with early Alzheimer's (MCI), HMTM treatment resulted in sustained improvement in cognition over pre-treatment baseline, and normalisation of brain atrophy to a rate similar to healthy individuals - For people with mild to moderate A...

  Servier unveils its 2030 ambition and reveals a new visual ide... - 06 October 2022 17:30

PARIS, Oct. 6, 2022 /PRNewswire-AsiaNet/ -- A new ambition by 2030 to accelerate its transformation dynamic A visual identity, a marker of the successful transformation of the Group, its ambitions and its renewal Servier today unveils its 2030 ambition as well as a new visual identity ...

  Global Milk Industry Digestibility Breakthrough - 05 October 2022 07:00

BRISBANE,Oct.5/Medianet International-AsiaNet/-- --World-first Haelen technology achieves 100% fresh, natural milk that is twice as digestible Naturo, the company behind the world-first patented 'Haelen' milk processing technology which gives fresh milk a 60-day shelf life has achieved anoth...

  Cambrex Announces Stability Storage Expansions in Ireland and... - 04 October 2022 18:00

EAST RUTHERFORD, NJ, Oct. 4, 2022 /PRNewswire-AsiaNet/ -- Cambrex today announced the expansion of their stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries. Q1 Scientific will ope...